Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.

Post time 2026-8-17 01:53:48

journal：Clinical Cancer Research

Authors：Sarah E. Lochrin; Hannah L. Kalvin; Monica F. Chen; James W. Smithy; Parisa Momtaz; Michael A. Postow; Shirlanna Station; Charlene Hochreiter; Katherine S. Panageas; Randy Yeh; Christopher A. Barker; Alexander N. Shoushtari

Published date：--

DOI：10.1158/1078-0432.ccr-26-1089

PDF link：https://aacrjournals.org/clincan ... 078/ccr-26-1089.pdf

Article link：https://doi.org/10.1158/1078-0432.ccr-26-1089

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2026-8-17 01:53:49

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma. Copy